Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study finds new blood test for heart disease risk:

This article was originally published in Clinica

Executive Summary

Levels of an enzyme in the blood could lead to a more accurate test for heart attack risk, according to a study published in The New England Journal of Medicine (October 23). Testing 604 patients for the enzyme myeloperoxidase predicted the early risk of myocardial infarction, as well as the risk of major adverse cardiac events, even when patients tested negative for Troponin T, said researchers at the Cleveland Clinic Foundation, Ohio.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065145

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel